I understand there may be some noise in the market regarding weight loss drugs, as such it has created a bit of a rift in prices of healthcare services relating to patient diets, lifestyles and procedures, could also be COVID lag/residue etc.
At this time however the Senior Living sector is expected to grow in America substantially in the next decade, thusly...
DaVita ( NYSE:DVA ) stock witnessed a significant surge as Novo Nordisk (NVO) unveiled promising results from its weight-loss drug study, offering newfound hope for patients battling chronic kidney disease. The groundbreaking findings have ignited investor optimism and reshaped the landscape for dialysis companies like DaVita and Fresenius Medical Care...
Fundamentally The Company have a really good quarterly results and is looking cheap at this price. Technically we can see buying pressure from good area of support. Price might go as high as 116.00/117.00 $ before next quarterly results.
The Medianline/Pitchfork Tool provides a high probability (~80%) to reach the Centerline from any parallel line.
That means, if you can figure out how to buy as low as possible, or short as high as possible, your trade works out ~80% of time.
Why would one not use this edge?
Ask me questions, I'l answer.
Earnings 2-22 AMC.
Price has broken up from a triangle and looks to be forming a flag.
Earnings close and there has been some Medicare reimbursement issues which could affect earnings.
No recommendation.
EPS (FWD)
6.40
PE (FWD)
12.96
Div Rate (TTM)
-
Short Interest
3.04%
Market Cap
$7.47B
DaVita Inc. provides kidney dialysis services for patients suffering...
Gap overhead.
Gaps can cause resistance at both the top and the bottom of the window.
Triangles are neutral until broken.
EPS (FWD)
6.40
PE (FWD)
11.38
Div Rate (TTM) * 0
Short Interest
3.45%
Market Cap
$6.56B
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and...
Symmetrical Triangle/neutral until broken.
Gap down after an earnings miss and a bad news event.
An Ohio court ruled in favor of an employer benefits plan run by Marietta Memorial Hospital surrounding out-of-network dialysis care. DaVita had argued that the plan violated federal law by not having an in-network option for dialysis and instead steered patients...
3-weeks ago DaVita Inc (DVA) recorded a 52-week Low & has just posted 2 consecutive up weeks. Historically, following this type of weekly reversal pattern, DVA had a tendency to continue this upward move (7-week interval).
7-week average return of 9.39%, win rate of 12 from 12, standard deviation 6.36%.
Disclaimer: This data is not financial advice. Past...
Buy (Entry Price) above the black line and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price.
Entry Price: $116.47
Target Price: $118.10
Stop Loss: $113.72
Corporate Profile
DaVita is a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe. The company is the largest provider of kidney care services in the U.S. and has been a leader in clinical quality and innovation for 20 years. Through DaVita Kidney Care, the company treats patients with...
